Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2307PDF: 1002HTML: 4948 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1816PDF: 840HTML: 183 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
871PDF: 490HTML: 1310 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1223PDF: 853HTML: 3369 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1245PDF: 726HTML: 1249 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1665PDF: 811HTML: 871jdoe, table 2 infections CML .doc: 205jdoe, table 1 infections CML .doc: 195 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
749PDF: 474HTML: 6274 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1617PDF: 807HTML: 827tile page: 171Table 1: 178 -
WHAT ARE FUNGAL INFECTIONS?
4276PDF: 2442HTML: 27646de Pauw: 252 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1396HTML: 334PDF: 971Suppl. Files: 477 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2021PDF: 988HTML: 704 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1500PDF: 925Suppl. Files: 463HTML: 248 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4874PDF: 1832HTML: 2730Untitled: 237 -
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1439PDF: 838HTML: 3126 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3040PDF: 1610HTML: 240 -
-
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1680PDF: 1023HTML: 375 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4010PDF: 1325HTML: 2288 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2009PDF: 1073HTML: 304 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2179PDF: 1200HTML: 281 -
FIRST TUNISIAN CLUSTER ADMISSIONS OF CRITICALLY ILL PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) : Multisystem inflammatory syndrome in children (MIS-C)
1380PDF: 533HTML: 200 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2216PDF: 1001HTML: 3011Untitled: 226 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2833PDF: 1005HTML: 648 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
778PDF: 675HTML: 108 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2954PDF: 1390HTML: 3583Untitled: 203Untitled: 216Untitled: 191 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2964PDF: 1364HTML: 164 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1516PDF: 802Suppl. Files: 338Html: 141 -
-
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
302PDF: 318HTML: 38







